A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2001
11/06/2001	US6312922 Complementary DNAs
11/06/2001	US6312907 An isolated nucleic acid encoding a gene for decorin binding protein from borrelia; diagnosis and therapy of lyme disease in humans and animals
11/06/2001	US6312899 A polynucleotide probe for the detection and diagnositic staging of lymphocyte differentiation
11/06/2001	US6312898 Diagnosing and treating subjects having increased risk for the development of the disease using polymerase chain reaction and/or sequencing methods to determine amino acid polymorphism in the protein
11/06/2001	US6312727 Delivery of nucleic acid materials
11/06/2001	US6312699 Genetic engineering of adenoviral fiber protein with caboxy end group
11/06/2001	US6312688 Tyrosine-phosphatase-related protein
11/06/2001	US6312683 Equine infectious anemia virus vectors
11/06/2001	US6312682 Retroviral vectors
11/06/2001	US6312681 Compositions and methods for the treatment of cancer using recombinant viral vector delivery systems
11/06/2001	US6312665 Aerosol formulations for buccal and pulmonary application
11/01/2001	WO2001081928A1 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine -1 (mic-1)
11/01/2001	WO2001081918A1 Transcriptionally regulated g protein-coupled receptor g2a
11/01/2001	WO2001081622A2 Diagnosis of diseases associated with dna repair
11/01/2001	WO2001081608A2 Viral vectors for use in monitoring hiv drug resistance
11/01/2001	WO2001081599A2 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors
11/01/2001	WO2001081590A2 Protein phosphatases
11/01/2001	WO2001081585A2 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001	WO2001081581A2 Compositions and methods for the therapy and diagnosis of acne vulgaris
11/01/2001	WO2001081577A2 Dna encoding the prost 03 polypeptide
11/01/2001	WO2001081574A2 Regulation of nf-at interacting protein nip 45 variant
11/01/2001	WO2001081570A2 Heteromultimeric ion channel receptor and uses thereof
11/01/2001	WO2001081562A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
11/01/2001	WO2001081554A1 Pneumovirus ns proteins antagonising the interferon (ifn) response
11/01/2001	WO2001081553A1 Alphavirus-based vectors for persistent infection
11/01/2001	WO2001081544A2 Identification and uses of a hyaluronan receptor
11/01/2001	WO2001081540A2 Growth factor which acts through erb b-4 rtk
11/01/2001	WO2001081408A2 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same
11/01/2001	WO2001081404A2 INDUCIBLE PLASMID VECTOR ENCODING TGF-β AND USES THEREOF
11/01/2001	WO2001081387A1 Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector
11/01/2001	WO2001081361A1 Compositions and method for diagnosing and treating conditions, disorders, or diseases involving cell death
11/01/2001	WO2001080902A2 A particulate complex for administering nucleic acid into a cell
11/01/2001	WO2001080901A2 Gene directed enzyme prodrug therapy (gdept) for cell ablation
11/01/2001	WO2001080900A2 Enhanced stabilised plasmid-lipid particle-mediated transfection using endosomal membrane
11/01/2001	WO2001080897A2 Compositions and methods for in vivo delivery of polynucleotide-based therapeutics
11/01/2001	WO2001080882A2 Methods and compositions for eliciting an immune response
11/01/2001	WO2001080875A1 A memory enhancing protein
11/01/2001	WO2001080873A2 Thrombopoietin receptor modulating peptide
11/01/2001	WO2001080840A2 Cytotoxic agents comprising single-stranded and/or looped dna
11/01/2001	WO2001080633A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
11/01/2001	WO2001037853A3 Methods and agents for the inhibition of smooth muscle cell proliferation
11/01/2001	WO2001036604A3 Nucleic acids encoding endotheliases, endotheliases and uses thereof
11/01/2001	WO2001036457A3 Chlamydia antigens and corresponding dna fragments and uses thereof
11/01/2001	WO2001032866A3 Hybrid adaptor receptors
11/01/2001	WO2001029084A3 Novel human proteins and polynucleotides encoding the same
11/01/2001	WO2001023522A8 Compositions and methods for p53-mediated repression of gene expression
11/01/2001	WO2001005937A3 Conversion of a watson-crick dna to a hoogsteen-paired duplex
11/01/2001	WO2000034483A3 Compounds and methods for treatment and diagnosis of chlamydial infection
11/01/2001	WO2000024780A9 Compositions and methods for treating polycystic kidney disease
11/01/2001	US20010036929 Dna repair
11/01/2001	US20010036927 Complexing
11/01/2001	US20010036926 Compound containing a labile disulfide bond
11/01/2001	US20010036925 Genetic engineering
11/01/2001	US20010036919 Preventing airway mucus production by administration of EGF-R antagonists
11/01/2001	US20010036655 Vaccine
11/01/2001	US20010036650 Isolated polynucleotide, polypeptide
11/01/2001	US20010036635 Cancer screening
11/01/2001	US20010036480 Particulate drug-containing products and method of manufacture
11/01/2001	US20010036460 Therapy for prostate cancer
11/01/2001	US20010036459 Cytotoxicity; therapeutic antibody
11/01/2001	US20010036454 Transfection of lung tissue
11/01/2001	EP1144642A3 Compounds and methods for treatment and diagnosis of chlamydial infection
11/01/2001	CA2410024A1 Identification and uses of a hyaluronan receptor
11/01/2001	CA2407515A1 A particulate complex for administering nucleic acid into a cell
11/01/2001	CA2407352A1 Compositions and methods for the therapy and diagnosis of acne vulgaris
11/01/2001	CA2407167A1 Thrombopoietin receptor modulating peptide
11/01/2001	CA2407074A1 Compositions and methods for in vivo delivery of polynucleotide-based therapeutics
11/01/2001	CA2407053A1 Pneumovirus ns proteins antagonize the interferon (ifn) response
11/01/2001	CA2407050A1 Alphavirus-based vectors for persistent infection
11/01/2001	CA2406855A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
11/01/2001	CA2406839A1 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same
11/01/2001	CA2406660A1 Heteromultimeric ion channel receptor and uses thereof
11/01/2001	CA2406639A1 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001	CA2406264A1 Protein phosphatases
11/01/2001	CA2406073A1 A protein kinase c variant to alter memory
11/01/2001	CA2405983A1 Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector
11/01/2001	CA2405680A1 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine -1 (mic-1)
11/01/2001	CA2405138A1 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors
11/01/2001	CA2404998A1 Cytotoxic agents
11/01/2001	CA2403916A1 Viral vectors for use in monitoring hiv drug resistance
10/2001
10/31/2001	EP1149917A2 Hepatitis B virus vectors for gene therapy
10/31/2001	EP1149916A2 Defective Adenoviruses and corresponding transcomplementant cell lines
10/31/2001	EP1149910A1 Pharmaceutical composition for treating papillomavirus tumours and infection
10/31/2001	EP1149909A1 Methods for regulating protein conformation using molecular chaperones
10/31/2001	EP1149908A1 TGF-beta type receptor cDNAs and uses thereof
10/31/2001	EP1149906A1 Thrombopoietin receptor modulating peptide
10/31/2001	EP1149905A1 Methods and compositions for polypeptide engineering
10/31/2001	EP1149904A1 Methods and compositions for polypeptide engineering
10/31/2001	EP1149903A1 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof
10/31/2001	EP1149582A2 Human G-protein chemokine receptor HDGNR10 (CCR5 receptor). Uses thereof
10/31/2001	EP1149168A2 Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins
10/31/2001	EP1149167A2 Viral vaccine
10/31/2001	EP1149166A2 GENES IDENTIFIED AS REQUIRED FOR PROLIFERATION IN $i(ESCHERICHIA COLI)
10/31/2001	EP1149161A2 Ribozymes directed against the catalytic subunit of the human telomerase (htert)
10/31/2001	EP1149158A1 Genetic and epigenetic regulation of abc transporters and ect0-phosphatases for the modulation of drug resistance
10/31/2001	EP1149114A2 Polypeptides involved in immune response
10/31/2001	EP1149112A2 Ewing's tumour antigen, nucleic acid and antibodies
10/31/2001	EP0975783B1 Retroviral vectors, method for the production and the use thereof for gene transfer in cd4-positive cells
10/31/2001	EP0902780B1 Quaternary cytofectins
10/31/2001	EP0842279B1 Helper viruses for preparing recombinant viral vectors

1 ... 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 ... 870